197 related articles for article (PubMed ID: 37525200)
1. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
[TBL] [Abstract][Full Text] [Related]
2. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
[TBL] [Abstract][Full Text] [Related]
3. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
[TBL] [Abstract][Full Text] [Related]
4. Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study.
Akkoyun EB; Most Z; Katragadda H; Yu A; Nassi L; Oakman N; Ginsburg S; Maamari M
Pediatr Rheumatol Online J; 2023 Nov; 21(1):141. PubMed ID: 37996856
[TBL] [Abstract][Full Text] [Related]
5. Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity.
Taddio A; Della Paolera S; Abbagnato L; Agrusti A; Badolato R; Biscaro F; Caorsi R; Consolaro A; Dellepiane RM; Fabi M; Floretta I; Gattorno M; Giangreco M; La Torre F; Maggio MC; Mambelli L; Mauro A; Mastrolia MV; Meneghel A; Montin D; Ricci F; Simonini G; Smarrazzo A; Sottile R; Stucchi S; Tardi M; Verdoni L; Zuccotti G; Zunica F; Ravelli A; Cattalini M;
Rheumatology (Oxford); 2024 Feb; 63(2):366-375. PubMed ID: 37647645
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study.
Licciardi F; Covizzi C; Dellepiane M; Olivini N; Mastrolia MV; Lo Vecchio A; Monno V; Tardi M; Mauro A; Alessio M; Filocamo G; Cattalini M; Taddio A; Caorsi R; Marseglia GL; La Torre F; Campana A; Simonini G; Ravelli A; Montin D
Front Pediatr; 2023; 11():1137051. PubMed ID: 37675397
[TBL] [Abstract][Full Text] [Related]
7. Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children.
Chang JC; Young CC; Muscal E; Sexson Tejtel SK; Newhams MM; Kucukak S; Crandall H; Maddux AB; Rowan CM; Halasa NB; Harvey HA; Hobbs CV; Hall MW; Kong M; Aguiar CL; Schuster JE; Fitzgerald JC; Singh AR; Wellnitz K; Nofziger RA; Cvijanovich NZ; Mack EH; Schwarz AJ; Heidemann SM; Newburger JW; Zambrano LD; Campbell AP; Patel MM; Randolph AG; Son MBF;
Arthritis Rheumatol; 2023 Aug; 75(8):1466-1476. PubMed ID: 36908050
[TBL] [Abstract][Full Text] [Related]
8. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
[TBL] [Abstract][Full Text] [Related]
9. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.
Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F
Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352
[TBL] [Abstract][Full Text] [Related]
10. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
[TBL] [Abstract][Full Text] [Related]
12. Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.
Vukomanovic V; Krasic S; Prijic S; Ninic S; Popovic S; Petrovic G; Ristic S; Simic R; Cerovic I; Nesic D
Pediatr Infect Dis J; 2021 Nov; 40(11):e390-e394. PubMed ID: 34260481
[TBL] [Abstract][Full Text] [Related]
13. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.
Yamaguchi Y; Takasawa K; Irabu H; Hiratoko K; Ichigi Y; Hirata K; Tamura Y; Murakoshi M; Yamashita M; Nakatani H; Shimoda M; Ishii T; Udagawa T; Shimizu M; Kanegane H; Morio T
J Infect Chemother; 2022 Jun; 28(6):814-818. PubMed ID: 35125343
[TBL] [Abstract][Full Text] [Related]
14. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S
JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic.
Della Paolera S; Valencic E; Piscianz E; Moressa V; Tommasini A; Sagredini R; Kiren V; Comar M; Taddio A
Front Pediatr; 2020; 8():624248. PubMed ID: 33708752
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Multisystem Inflammatory Syndrome in Children.
McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
[TBL] [Abstract][Full Text] [Related]
17. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine for the treatment of multisystem inflammatory syndrome in children with coronary artery aneurysms.
Hiraoka T; Tsuge M; Kondo Y
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35680277
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review.
Velusamy Y; Vivekanandan G; Romli MH; Shankar A; Karuppiah T; Yubbu P
Turk J Pediatr; 2023; 65(5):719-738. PubMed ID: 37853964
[TBL] [Abstract][Full Text] [Related]
20. New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults.
Chen CJ; Kao HY; Huang CH; Li CJ; Hung CH; Yong SB
Ital J Pediatr; 2024 Jan; 50(1):18. PubMed ID: 38273368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
